Document Details
Form
Filing Date
Feb 25, 2019
Document Date
Feb 19, 2019
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Xeris Biopharma Holdings, Inc.
Issuer
XERIS PHARMACEUTICALS INC
Filer
JOHNSON KENNETH ERLAND